158 related articles for article (PubMed ID: 6957411)
1. Self-renewal and commitment to differentiation of human leukemic promyelocytic cells (HL-60).
Fibach E; Peled T; Rachmilewitz EA
J Cell Physiol; 1982 Oct; 113(1):152-8. PubMed ID: 6957411
[TBL] [Abstract][Full Text] [Related]
2. Commitment to differentiation of human promyelocytic leukemia cells (HL60): an all-or-none event preceded by reversible losses of self-renewal potential.
von Melchner H; Höffken K
J Cell Physiol; 1985 Dec; 125(3):573-81. PubMed ID: 3864784
[TBL] [Abstract][Full Text] [Related]
3. Analysis of commitment of human leukemia HL-60 cells to terminal granulocytic maturation.
Tsiftsoglou AS; Wong W; Hyman R; Minden M; Robinson SH
Cancer Res; 1985 May; 45(5):2334-9. PubMed ID: 3857118
[TBL] [Abstract][Full Text] [Related]
4. Identification of a regulatory peptide distinct from normal granulocyte-derived hemoregulatory peptide produced by human promyelocytic HL-60 leukemia cells after differentiation induction with retinoic acid.
Paukovits JB; Paukovits WR; Laerum OD
Cancer Res; 1986 Sep; 46(9):4444-8. PubMed ID: 3460696
[TBL] [Abstract][Full Text] [Related]
5. Changes in self-renewal potential of human leukemic cells (K562): a bidirectional stochastic process.
von Mechner H; Höffken K
J Cell Physiol; 1985 May; 123(2):249-56. PubMed ID: 3856568
[TBL] [Abstract][Full Text] [Related]
6. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of leukemic cell lines: a review focusing on murine erythroleukemia and human HL-60 cells.
Tsiftsoglou AS; Robinson SH
Int J Cell Cloning; 1985 Nov; 3(6):349-66. PubMed ID: 3905996
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
Schwartz EL; Sartorelli AC
Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of growth but not differentiation of normal and leukemic myeloid cells by methylthioadenosine.
Riscoe MK; Schwamborn J; Ferro AJ; Olson KD; Fitchen JH
Cancer Res; 1987 Jul; 47(14):3830-4. PubMed ID: 3474063
[TBL] [Abstract][Full Text] [Related]
10. Murine flt3 ligand protects M1 leukemic cells from LIF-induced differentiation and suppression of self-renewal.
Begley CG; Rasko JE; Curtis D; Takagi K; Metcalf D; Hilton D; Roberts B; Nicola NA; Rossner MT
Exp Hematol; 1996 Aug; 24(10):1247-57. PubMed ID: 8765501
[TBL] [Abstract][Full Text] [Related]
11. Induction of differentiation in HL-60 promyelocytic cells: a comparative study in two sublines.
Kaplinsky C; Estrov Z; Freedman MH; Cohen A
Blood Cells; 1986; 11(3):459-68. PubMed ID: 3461855
[TBL] [Abstract][Full Text] [Related]
12. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
[TBL] [Abstract][Full Text] [Related]
13. Induction of differentiation in human myeloid leukemic cells by proteolytic enzymes.
Fibach E; Treves A; Kidron M; Mayer M
J Cell Physiol; 1985 May; 123(2):228-34. PubMed ID: 3884635
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation.
Schwartz EL; Brown BJ; Nierenburg M; Marsh JC; Sartorelli AC
Cancer Res; 1983 Jun; 43(6):2725-30. PubMed ID: 6573951
[TBL] [Abstract][Full Text] [Related]
15. Control of normal differentiation of myeloid leukemic cells. XIII. Inducibility for some stages of differentiation by dimethylsulfoxide and its disassociation from inducibility by MGI.
Maeda S; Sachs L
J Cell Physiol; 1978 Feb; 94(2):181-5. PubMed ID: 304449
[TBL] [Abstract][Full Text] [Related]
16. Expression of maturation-specific nuclear antigens in differentiating human myeloid leukemia cells.
Murao S; Epstein AL; Clevenger CV; Huberman E
Cancer Res; 1985 Feb; 45(2):791-5. PubMed ID: 3881172
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
[TBL] [Abstract][Full Text] [Related]
18. The study of human myeloid differentiation using bromodeoxyuridine (BrdU).
Keoffler HP; Yen J; Carlson J
J Cell Physiol; 1983 Jul; 116(1):111-7. PubMed ID: 6574132
[TBL] [Abstract][Full Text] [Related]
19. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
20. New facts and speculations on human myeloid leukemias.
Breitman TR; Gallo RC
Blood Cells; 1981; 7(1):79-89. PubMed ID: 6964818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
